Studi Evaluasi Kemampuan Arrester Sebagai Pengaman Transformator Di Gardu Induk 150 KV Palur

The substation takes a role as a distributor of electricity from the transmission system to the distribution system and to be distributed to consumers. At the substation, there are transformers that are to reduce the voltage which is from high voltage to medium voltage. There is a safety device which is installed in the transformer, namely arrester. Arrester is a safety device used to protect arresters from overvoltages caused by lightning surges. For maximum protection, arresters must be placed as close to the protected device as possible. The optimum distance for the installation of arresters must be determined so that they can be installed optimally as needed. This study focuses on one transformer and one arrester. The type of transformer used is CG PAUWELS type ORF.60 / 275 and arrester with transformer 1 which is PASSONI VILLA type SCB 170-120 / 150. In determining the safe distance of the arrester installation, we used optimization method by calculating the maximum distance of the traffic with arresters in order to get optimal protection. The analysis obtained from the calculation shows that the maximum distance of the arrester with a transformer is 22.5 m. Meanwhile, in reality, we found that the distance of the arrester with a transformer is only 4.2 m. Eventually, we get the conclusion that the arrester that is installed on transformer 1 is still in the safe box of the transformer since it is still below the maximum distance of the arrester with the transformer

ArtCodes

In an experiment with a split brain patient, when the patient’s right brain received a written instruction to stand up, the patient would stand up. But when asked why did he stand up, the patient’s left side of the brain (which control speech) would make up a story that only seems logical to the patient, such as, “I’m standing up to get some water.” This shows the patient’s left side of the brain receives information from the right side unconsciously

Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum

The airways of patients with cystic fibrosis (CF) are frequently colonized by various filamentous fungi, mainly Aspergillus fumigatus and Scedosporium species. To establish within the respiratory tract and cause an infection, these opportunistic fungi express pathogenic factors allowing adherence to the host tissues, uptake of extracellular iron, or evasion to the host immune response. During the colonization process, inhaled conidia and the subsequent hyphae are exposed to reactive oxygen species (ROS) and reactive nitrogen species (RNS) released by phagocytic cells, which cause in the fungal cells an oxidative stress and a nitrosative stress, respectively. To cope with these constraints, fungal pathogens have developed various mechanisms that protect the fungus against ROS and RNS, including enzymatic antioxidant systems. In this review, we summarize the different works performed on ROS- and RNS-detoxifying enzymes in fungi commonly encountered in the airways of CF patients and highlight their role in pathogenesis of the airway colonization or respiratory infections. The potential of these enzymes as serodiagnostic tools is also emphasized. In addition, taking advantage of the recent availability of the whole genome sequence of S. apiospermum, we identified the various genes encoding ROS- and RNS-detoxifying enzymes, which pave the way for future investigations on the role of these enzymes in pathogenesis of these emerging species since they may constitute new therapeutics targets

Intraperitoneal drain placement and outcomes after elective colorectal surgery: international matched, prospective, cohort study

Despite current guidelines, intraperitoneal drain placement after elective colorectal surgery remains widespread. Drains were not associated with earlier detection of intraperitoneal collections, but were associated with prolonged hospital stay and increased risk of surgical-site infections.Background Many surgeons routinely place intraperitoneal drains after elective colorectal surgery. However, enhanced recovery after surgery guidelines recommend against their routine use owing to a lack of clear clinical benefit. This study aimed to describe international variation in intraperitoneal drain placement and the safety of this practice. Methods COMPASS (COMPlicAted intra-abdominal collectionS after colorectal Surgery) was a prospective, international, cohort study which enrolled consecutive adults undergoing elective colorectal surgery (February to March 2020). The primary outcome was the rate of intraperitoneal drain placement. Secondary outcomes included: rate and time to diagnosis of postoperative intraperitoneal collections; rate of surgical site infections (SSIs); time to discharge; and 30-day major postoperative complications (Clavien-Dindo grade at least III). After propensity score matching, multivariable logistic regression and Cox proportional hazards regression were used to estimate the independent association of the secondary outcomes with drain placement. Results Overall, 1805 patients from 22 countries were included (798 women, 44.2 per cent; median age 67.0 years). The drain insertion rate was 51.9 per cent (937 patients). After matching, drains were not associated with reduced rates (odds ratio (OR) 1.33, 95 per cent c.i. 0.79 to 2.23; P = 0.287) or earlier detection (hazard ratio (HR) 0.87, 0.33 to 2.31; P = 0.780) of collections. Although not associated with worse major postoperative complications (OR 1.09, 0.68 to 1.75; P = 0.709), drains were associated with delayed hospital discharge (HR 0.58, 0.52 to 0.66; P < 0.001) and an increased risk of SSIs (OR 2.47, 1.50 to 4.05; P < 0.001). Conclusion Intraperitoneal drain placement after elective colorectal surgery is not associated with earlier detection of postoperative collections, but prolongs hospital stay and increases SSI risk

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015 : the Global Burden of Disease Study 2015

Background Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015. Methods For countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification. Findings Global HIV incidence reached its peak in 1997, at 3.3 million new infections (95% uncertainty interval [UI] 3.1-3.4 million). Annual incidence has stayed relatively constant at about 2.6 million per year (range 2.5-2.8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38.8 million (95% UI 37.6-40.4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1.8 million deaths (95% UI 1.7-1.9 million) in 2005, to 1.2 million deaths (1.1-1.3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections. Interpretation Scale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY licensePeer reviewe

Solving Eventual Bonding Quality To Enhance Adhesion For QFN Packages

Many of the components used extensively in today's handheld market are beginning to migrate from traditional lead frame design to lead less or non leaded. The primary driver for handheld manufacturers is the saved PC board space created by these components' smaller mounting areas. In addition, most components also have reductions in weight and height, as well as an improved electrical performance. As critical chip scale packages are converted to non- leaded designs, the additional space saved can be allocated to new components for added device functionality Similar to leaded components, non leaded designs use wire bond as the primary interconnection between the IC and the frame. However, due to the unique land site geometry and form factor density, traditional wire bond processes may not produce high yielding production. For these designs, additional wire bond capabilities and alternate processes are needed to produce acceptable production yields. This paper discusses the eventual challenges of wire bond for QFN package designs and describes how new wire bond capabilities and process optimization can improve production yields but on top of the impact need to be consider as well during the higher force impact which could deteriorate the looping profile on the adjacent wire. The advantages of the conversion of the design which could improve the conversion rate on the production

Q-switched thulium-doped fibre laser operating at 1900 nm using multi-walled carbon nanotubes saturable absorber

Simple, low-cost and stable passive Q-switched thulium-doped fibre lasers (TDFLs) operating at 1892.4 and 1910.8 nm are demonstrated using 802 and 1552 nm pumping schemes, respectively, in conjunction with a multi-walled carbon nanotubes (MWCNTs) saturable absorber (SA). The MWCNTs composite is prepared by mixing the MWCNTs homogeneous solution into a dilute polyvinyl alcohol (PVA) polymer solution before it is left to dry at room temperature to produce thin film. Then the film is sandwiched between two FC/PC fibre connectors and integrated into the laser cavity for Q-switching pulse generation. The pulse repetition rate of the TDFL configured with 802 nm pump can be tuned from 3.8 to 4.6 kHz, whereas the corresponding pulse width reduces from 22.1 to 18.3 μs as the pump power is increased from 187.3 to 194.2 mW. On the other hand, with 1552 nm pumping, the TDFL generates optical pulse train with a repetition rate ranging from 13.1 to 21.7 kHz with a pulse width of 11.5 7.9 μs when the pump power is tuned from 302.2 to 382.1 mW. A higher performance Q-switched TDFL is expected to be achieved with the optimisation of the MWCNT-SA saturable absorber and laser cavity